Baxter (BAX) Declares $0.19 Quarterly Dividend; Approves $2B Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Authorization
November 13, 2018 9:15 AM ESTDEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, announced today a quarterly cash dividend and an expanded authorization for its share repurchase program.
The Board of Directors of Baxter has declared a quarterly cash dividend of $0.19 per share of common stock, payable on Jan. 2, 2019, to stockholders of record as of Dec. 3, 2018. The indicated annual dividend rate is $0.76 per share of common stock.
Baxters Board of Directors has also approved a $2.0 billion increase in authorization for the companys existing share repurchase plan. Based... More



